agreement-handshake

Pressmaster / shutterstock.com

1 November 2016Big Pharma

Medivir to sell BioPhausia to Karo Pharma

Sweden-based pharmaceutical company Medivir has entered into an agreement with Karo Pharma, also based in Sweden, under which Medivir will sell its subsidiary BioPhausia to Karo.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Court denies Regeneron bid to halt copy of blockbuster eye drug

Interview: Klaus Grabinski, UPC Court of Appeal president

Gilead scores win in fake HIV drug dispute

Polsinelli grows roster with ex-corporate counsel

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

Sandoz wins $137.2m payout for lost profits in generic launch

Sanofi signs global rights deal to develop rare cancer therapy

Unified Patent Court visualised: Cases, divisions, and classes in charts